BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 31145370)

  • 1. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
    Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
    J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
    Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
    J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.
    Nagasawa M; Yamamoto K; Rakugi H; Takeda M; Akasaka H; Umakoshi H; Tsuiki M; Takeda Y; Kurihara I; Itoh H; Ichijo T; Katabami T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Ogo A; Okamura S; Miyauchi S; Yanase T; Suzuki T; Kawamura T; Naruse M;
    J Hypertens; 2019 Jul; 37(7):1493-1499. PubMed ID: 31033727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary aldosteronism: diagnostic and treatment strategies.
    Mattsson C; Young WF
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):198-208; quiz, 1 p following 230. PubMed ID: 16932426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
    Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
    Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
    Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.
    Ohno Y; Sone M; Inagaki N; Kawashima A; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Ichijo T; Katabami T; Wada N; Sakamoto R; Ogawa Y; Yoshimoto T; Yamada T; Kawashima J; Matsuda Y; Kobayashi H; Kamemura K; Yamamoto K; Otsuki M; Okamura S; Izawa S; Okamoto R; Tamura K; Tanabe A; Naruse M;
    Hypertension; 2020 Jun; 75(6):1475-1482. PubMed ID: 32248705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism.
    Nakamaru R; Yamamoto K; Akasaka H; Rakugi H; Kurihara I; Yoneda T; Ichijo T; Katabami T; Tsuiki M; Wada N; Yamada T; Kobayashi H; Tamura K; Ogawa Y; Kawashima J; Inagaki N; Fujita M; Watanabe M; Kamemura K; Okamura S; Tanabe A; Naruse M;
    Sci Rep; 2021 Mar; 11(1):6925. PubMed ID: 33767283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
    Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism.
    Sukor N; Kogovsek C; Gordon RD; Robson D; Stowasser M
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1360-4. PubMed ID: 20089615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
    Weiner ID
    Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism.
    Williams TA; Burrello J; Sechi LA; Fardella CE; Matrozova J; Adolf C; Baudrand R; Bernardi S; Beuschlein F; Catena C; Doumas M; Fallo F; Giacchetti G; Heinrich DA; Saint-Hilary G; Jansen PM; Januszewicz A; Kocjan T; Nishikawa T; Quinkler M; Satoh F; Umakoshi H; Widimský J; Hahner S; Douma S; Stowasser M; Mulatero P; Reincke M
    Hypertension; 2018 Sep; 72(3):641-649. PubMed ID: 29987100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
    Swearingen AJ; Kahramangil B; Monteiro R; Krishnamurthy V; Jin J; Shin J; Siperstein A; Berber E
    Surgery; 2018 Apr; 163(4):807-810. PubMed ID: 29249599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
    Kline GA; Pasieka JL; Harvey A; So B; Dias VC
    Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical Evaluation by Confirmatory Tests after Unilateral Adrenalectomy for Primary Aldosteronism.
    Murasawa S; Kageyama K; Usutani M; Asari Y; Kinoshita N; Nakada Y; Watanuki Y; Takayasu S; Daimon M
    J Renin Angiotensin Aldosterone Syst; 2023; 2023():5732812. PubMed ID: 37265473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.
    Holaj R; Rosa J; Zelinka T; Štrauch B; Petrák O; Indra T; Šomlóová Z; Michalský D; Novák K; Wichterle D; Widimský J
    J Hypertens; 2015 Apr; 33(4):874-82; discussion 882. PubMed ID: 25490707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.